EDT Matinas BioPharma (MTNB) files to sell 16.9M shares of common stock for holdersStay Ahead of the Market: Discover outperforming ...

Certara Inc. surged by 22.84 percent on Friday, a third straight day, as investors bought up on its recent release of a new version of the Simcyp Simulator to support physiologically-based ...

AngloGold shares rallied for a third straight day on Friday, adding 10.14 percent to finish at $42.79 apiece, in line with gold prices hitting a new record high. As of 4:22 PM EDT on Friday, spot ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Oslo: LYTIX), a clinical stage immuno-oncology company, has today published its Annual Report for 2024, which was approved by the board of directors on April 9, ...

Revenue-generating with an exciting, diversified, largely externally funded, advanced development pipeline and multiple upcoming catalysts. Recent highlights: Mr. Ben-Asher continued: "Having ...

TORONTO (AP) — TORONTO (AP) — COSCIENS Biopharma Inc. (CSCI) on Wednesday reported a loss of $6.7 million in its fourth quarter. The Toronto-based company said it had a loss of $2.15 per share.

Shipping and logistics giant DHL Group is earmarking 2 billion euros ($2.2 billion) to bulk up its healthcare supply chain operations in order to meet growing demand from the biopharma industry.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Xeris Biopharma Holdings, Inc. before investing. In this article, we go over a ...

YONGIN, South Korea, April 9, 2025 /PRNewswire/ -- GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly ...

OLEAN — West Greene Street from South Union Street to South 2nd Street was closed Thursday due to an emergency street dig being completed by contracto ...

About 16.5 billion euros ($18 billion) worth of biopharma investment in the EU-27 territories could be at risk within just the next three months, EFPIA said, citing a CEO survey conducted last ...